167 related articles for article (PubMed ID: 31115857)
1. Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients.
Chelle P; Yeung CHT; Bonanad S; Morales Muñoz JC; Ozelo MC; Megías Vericat JE; Iorio A; Spears J; Mir R; Edginton A
J Pharmacokinet Pharmacodyn; 2019 Oct; 46(5):427-438. PubMed ID: 31115857
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate
Chelle P; Yeung CHT; Croteau SE; Lissick J; Balasa V; Ashburner C; Park YS; Bonanad S; Megías-Vericat JE; Nagao A; Wynn T; Corrales-Medina F; Tran H; Sharathkumar A; Chitlur M; Sarmiento S; Edginton A; Iorio A
Clin Pharmacokinet; 2020 Feb; 59(2):245-256. PubMed ID: 31435896
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project.
Hajducek DM; Chelle P; Hermans C; Iorio A; McEneny-King A; Yu J; Edginton A
Haemophilia; 2020 May; 26(3):384-400. PubMed ID: 32281726
[TBL] [Abstract][Full Text] [Related]
4. Development of a Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): Study Protocol.
Iorio A; Keepanasseril A; Foster G; Navarro-Ruan T; McEneny-King A; Edginton AN; Thabane L;
JMIR Res Protoc; 2016 Dec; 5(4):e239. PubMed ID: 27977390
[TBL] [Abstract][Full Text] [Related]
5. Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo).
McEneny-King A; Foster G; Iorio A; Edginton AN
JMIR Res Protoc; 2016 Dec; 5(4):e232. PubMed ID: 27927609
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of Web Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): Patterns of blood sampling and patient characteristics among clinician users.
McEneny-King A; Yeung CH; Edginton AN; Iorio A; Croteau SE
Haemophilia; 2020 Jan; 26(1):56-63. PubMed ID: 31742831
[TBL] [Abstract][Full Text] [Related]
7. Impact of capacity-limited binding on recombinant factor VIII and von Willebrand factor pharmacokinetics in hemophilia A rats.
Vargas Christensen I; Loftager M; Rode F; Mørck Nielsen H; Kreilgaard M; Larsen MS
J Thromb Haemost; 2019 Jun; 17(6):964-974. PubMed ID: 30924607
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of recombinant coagulation factor VIII-SingleChain in patients with severe hemophilia A.
Zhang Y; Roberts J; Tortorici M; Veldman A; St Ledger K; Feussner A; Sidhu J
J Thromb Haemost; 2017 Jun; 15(6):1106-1114. PubMed ID: 28244200
[TBL] [Abstract][Full Text] [Related]
9. External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data.
Chelle P; Hajducek D; Mahdi M; Young S; Iorio A; Silvertown J; Edginton A
Res Pract Thromb Haemost; 2021 Oct; 5(7):e12599. PubMed ID: 34761154
[TBL] [Abstract][Full Text] [Related]
10. A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A Patients.
Bukkems LH; Heijdra JM; Mathias M; Collins PW; Hay CRM; Tait RC; Mangles S; Myers B; Evans G; Bailiff B; Curry N; Payne J; Austin S; Goedhart TMHJ; Leebeek FWG; Meijer K; Fijnvandraat K; Chowdary P; Mathôt RAA; Cnossen MH;
Thromb Haemost; 2020 May; 120(5):747-757. PubMed ID: 32369846
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization.
McEneny-King A; Chelle P; Foster G; Keepanasseril A; Iorio A; Edginton AN
J Pharmacokinet Pharmacodyn; 2019 Oct; 46(5):411-426. PubMed ID: 31104228
[TBL] [Abstract][Full Text] [Related]
12. A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients.
Yu JK; Iorio A; Edginton AN
Thromb Res; 2020 Dec; 196():550-558. PubMed ID: 33157394
[TBL] [Abstract][Full Text] [Related]
13. Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII.
Preijers T; van Moort I; Fijnvandraat K; Leebeek FWG; Cnossen MH; Mathôt RAA;
Thromb Haemost; 2018 Mar; 118(3):514-525. PubMed ID: 29534249
[TBL] [Abstract][Full Text] [Related]
14. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
[TBL] [Abstract][Full Text] [Related]
15. Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients.
Megías-Vericat JE; Bonanad S; Haya S; Cid AR; Marqués MR; Ferrada A; Monte-Boquet E; Pérez-Alenda S; Bosch P; Querol-Giner F; Poveda JL
Thromb Res; 2021 Sep; 205():99-105. PubMed ID: 34293540
[TBL] [Abstract][Full Text] [Related]
16. Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A.
Delavenne X; Dargaud Y; Ollier E; Négrier C
Br J Clin Pharmacol; 2019 Apr; 85(4):771-781. PubMed ID: 30633808
[TBL] [Abstract][Full Text] [Related]
17. Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS-Hemo platform.
Chelle P; Hajducek D; Thibaudeau K; Hobson N; Iorio A; Shapiro A; Edginton A
Haemophilia; 2024 May; ():. PubMed ID: 38698539
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of recombinant factor VIII Fc fusion protein.
Nestorov I; Neelakantan S; Ludden TM; Li S; Jiang H; Rogge M
Clin Pharmacol Drug Dev; 2015; 4(3):163-74. PubMed ID: 27140796
[TBL] [Abstract][Full Text] [Related]
19. A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates.
Chelle P; Iorio A; Edginton AN
J Thromb Haemost; 2022 Sep; 20(9):2012-2021. PubMed ID: 35753074
[TBL] [Abstract][Full Text] [Related]
20. A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients.
Hazendonk H; Fijnvandraat K; Lock J; Driessens M; van der Meer F; Meijer K; Kruip M; Gorkom BL; Peters M; de Wildt S; Leebeek F; Cnossen M; Mathôt R;
Haematologica; 2016 Oct; 101(10):1159-1169. PubMed ID: 27390359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
